57 results
8-K
EX-10.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
voluntarily or involuntarily, initiated, conducted or issued, or caused to be initiated, conducted or issued, any recall, field correction, market
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
424B4
q5nzlxr 4j0
20 Apr 23
Prospectus supplement with pricing info
6:03pm
8-K
EX-1.1
i07sj4t
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B4
2w770inr 34d11ku1gum
21 May 20
Prospectus supplement with pricing info
6:04am